Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grossman, R. I.
Right arrow Articles by Bernat, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grossman, R. I.
Right arrow Articles by Bernat, J. L.
Related Collections
Right arrow All Imaging
Right arrow MRI
Right arrow All Ethics in Neurology/Legal issues
Neurology, Vol. 62, Issue 6, 849-850, March 23, 2004

EDITORIALS

Incidental research imaging findings: Pandora’s costly box

Robert I. Grossman and James L. Bernat

You have reached the most complete version of this article accessible without further authentication.
More complete versions are available.
Link to article

Article topics:




This article has been cited by other articles:


Home page
 J Law Med EthicsHome page
F. G. Miller, M. M. Mello, and S. Joffe
Incidental findings in human subjects research: what do investigators owe research participants?
J. Law Med. Ethics, June 1, 2008; 36(2): 271 - 279.
[PDF]

Home page
 J Law Med EthicsHome page
J. Illes and V. N. Chin
Bridging philosophical and practical implications of incidental findings in brain research.
J. Law Med. Ethics, June 1, 2008; 36(2): 298 - 304.
[PDF]

Home page
 StrokeHome page
P. D. Schellinger and J. B. Fiebach
Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours: Pro
Stroke, May 1, 2005; 36(5): 1098 - 1101.
[Full Text] [PDF]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grossman, R. I.
Right arrow Articles by Bernat, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grossman, R. I.
Right arrow Articles by Bernat, J. L.
Related Collections
Right arrow All Imaging
Right arrow MRI
Right arrow All Ethics in Neurology/Legal issues